In pursuit of the elusive stem cell
New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.
New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.
Lustgarten Foundation names MIT laboratory to improve understanding and treatment of a deadly disease
Research team shows the power of proteomics to discover new drug targets and help develop therapeutic strategies with fewer long-term side effects.
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
CSAIL wireless system suggests future where doctors could implant sensors to track tumors or even dispense drugs.
Machine-learning system determines the fewest, smallest doses that could still shrink brain tumors.
Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects.
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
Mechanism-based cancer prevention is poised to further decrease the numbers of U.S. cancer deaths, says MIT professor emerita.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumors.
A drug treatment that mimics fasting can also provide the same benefit, study finds.